Targeting Akt reactivation following mTOR inhibition in breast cancer treatment

被引：0
|
作者：
Alayev, Anya [1 ]
Snyder, Rose B. [1 ]
Holz, Marina K. [1 ]
机构：
[1] Yeshiva Univ, New York, NY 10033 USA
来源：
MOLECULAR CANCER RESEARCH | 2013年 / 11卷
关键词：
D O I：
10.1158/1557-3125.ADVBC-A068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A068
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
    Sara E. Nunnery
    Ingrid A. Mayer
    Drugs, 2020, 80 : 1685 - 1697
  • [22] Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
    Nunnery, Sara E.
    Mayer, Ingrid A.
    DRUGS, 2020, 80 (16) : 1685 - 1697
  • [23] Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
    Cheng, Haiying
    Shcherba, Marina
    Pendurti, Gopichand
    Liang, Yuanxin
    Piperdi, Bilal
    Perez-Soler, Roman
    LUNG CANCER MANAGEMENT, 2014, 3 (01) : 67 - 75
  • [24] Combined inhibition of AKT & TBK1 for the treatment of breast cancer
    Habelhah, Hasem
    Zhnag, Laiqun
    CANCER RESEARCH, 2020, 80 (16)
  • [25] mTOR inhibition in management of advanced breast cancer
    Nag, Shona
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2012, 33 (02) : 89 - 94
  • [26] Inhibition of mTOR signaling by psoralidin in breast cancer
    Damodaran, Chendil
    Kumar, Raj
    Rohr, Jurgen
    CANCER RESEARCH, 2010, 70
  • [27] The Role of Mammalian Target of Rapamycin (mTOR) Inhibition in the Treatment of Advanced Breast Cancer
    Michael Gnant
    Current Oncology Reports, 2013, 15 : 14 - 23
  • [28] The Role of Mammalian Target of Rapamycin (mTOR) Inhibition in the Treatment of Advanced Breast Cancer
    Gnant, Michael
    CURRENT ONCOLOGY REPORTS, 2013, 15 (01) : 14 - 23
  • [29] Inhibition of Akt/mTOR pathway overcomes intrinsic resistance to dasatinib in triple-negative breast cancer
    Haga, Yuya
    Higashisaka, Kazuma
    Yang, Lili
    Sekine, Naoki
    Lin, Ying
    Tsujino, Hirofumi
    Nagano, Kazuya
    Tsutsumi, Yasuo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (04) : 672 - 678
  • [30] Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer
    Sharma, VarRuchi
    Sharma, Anil K.
    Punj, Vasu
    Priya, Panneerselvam
    SEMINARS IN CANCER BIOLOGY, 2019, 59 : 133 - 146
12345